Your browser doesn't support javascript.
loading
[Efficacy and safety of oral pyrotinib in HER2 positive metastatic breast cancer: real-world practice].
Song, G H; Li, H P; DI, L J; Yan, Y; Jiang, H F; Xu, L; Wan, D G; Li, Y; Wang, M P; Xiao, Y; Zhang, R Y; Ran, R; Wang, H.
Afiliação
  • Song GH; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Li HP; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • DI LJ; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Yan Y; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Jiang HF; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Xu L; Breast Disease Center, Peking University First Hospital, Beijing 100034, China.
  • Wan DG; Department of TCM Oncology, China-Japan Friendship Hospital, Beijing 100029, China.
  • Li Y; Department of Oncology, General Hospital of PLA, Beijing 100853, China.
  • Wang MP; Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
  • Xiao Y; Department of Tumor Chemotherapy and Radiation Sickness, Peking University Third Hospital, Beijing 100191, China.
  • Zhang RY; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Ran R; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
  • Wang H; Key Laboratory of Carcinogenesis and Translational Research, Ministry of Education; Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
Beijing Da Xue Xue Bao Yi Xue Ban ; 52(2): 254-260, 2020 Apr 18.
Article em Zh | MEDLINE | ID: mdl-32306007
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias da Mama / Aminoquinolinas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged País/Região como assunto: Asia Idioma: Zh Revista: Beijing Da Xue Xue Bao Yi Xue Ban Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Acrilamidas / Neoplasias da Mama / Aminoquinolinas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Humans / Middle aged País/Região como assunto: Asia Idioma: Zh Revista: Beijing Da Xue Xue Bao Yi Xue Ban Assunto da revista: MEDICINA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China